Meloxicam and Aleve (naproxen sodium) provide similar levels of pain relief, but meloxicam is a prescription medication that works differently enough to matter. In head-to-head clinical trials, meloxicam 7.5 mg once daily matched naproxen 750 mg daily across nearly all pain measures in patients with rheumatoid arthritis. So “stronger” isn’t quite the right word. The real differences lie in how each drug targets inflammation, how long it lasts, and what side effects you’re more likely to experience.
How They Compare for Pain Relief
A double-blind trial of nearly 380 patients with rheumatoid arthritis found no significant difference between meloxicam 7.5 mg (taken once daily) and naproxen 750 mg on the primary measures that matter most: patient-rated pain relief, investigator-rated effectiveness, and the number of painful or swollen joints. Out of ten secondary measures, naproxen came out ahead on only two, including a swollen joint severity score. For most people, the two drugs land in the same ballpark.
The federal Agency for Healthcare Research and Quality groups NSAIDs into comparable dose tiers. At their medium doses, meloxicam sits at 7.5 mg once daily while naproxen sits at 500 mg twice daily (1,000 mg total). At maximum doses, meloxicam tops out at 15 mg once daily and naproxen at 1,250 mg per day. These aren’t exact equivalents, but they reflect the dosing ranges that produce similar clinical effects in osteoarthritis trials.
It’s worth noting that Aleve, the over-the-counter version, caps you at a lower dose than prescription naproxen. Each Aleve tablet contains 220 mg of naproxen sodium, and the label directs you to take one tablet every 8 to 12 hours, up to two or three per day. That puts OTC Aleve at roughly 440 to 660 mg daily, which is below the prescription medium dose. So if you’re comparing prescription meloxicam at 15 mg to OTC Aleve at label doses, meloxicam may feel more effective simply because you’re comparing a full prescription dose to a conservative over-the-counter one.
Why Meloxicam Targets Inflammation Differently
Both meloxicam and naproxen belong to the NSAID family, but they don’t block the same enzymes in the same proportions. Your body produces two types of COX enzymes. COX-1 handles everyday maintenance: protecting your stomach lining and helping platelets function. COX-2 ramps up during injury and inflammation, and blocking it is what actually reduces pain.
Meloxicam is far more selective for COX-2. In lab measurements, its selectivity ratio for COX-2 over COX-1 is about 18 to 1. Naproxen, by contrast, is classified as a nonselective inhibitor, meaning it blocks both enzymes at roughly equal rates. In real-world blood tests, naproxen at 500 mg twice daily inhibited 95% of COX-1 and about 72% of COX-2. Meloxicam at 15 mg daily inhibited only 53% of COX-1 while hitting 78% of COX-2.
This selectivity is the key practical difference. Meloxicam gets slightly more anti-inflammatory effect per unit of stomach irritation. Naproxen’s heavier COX-1 blockade is what makes it rougher on the digestive tract but also gives it a stronger effect on platelet function, which some cardiologists actually consider a benefit.
Duration and Dosing Convenience
Meloxicam has a half-life of 15 to 20 hours, which is why it works as a once-daily medication. You take one pill in the morning and it maintains steady levels through the following day. Both naproxen and meloxicam are considered long-acting NSAIDs, but meloxicam’s dosing is simpler. Prescription naproxen typically requires twice-daily dosing, and OTC Aleve needs two to three doses spread throughout the day.
For chronic conditions like osteoarthritis or rheumatoid arthritis, that once-daily convenience matters. It’s easier to stay consistent, and consistent dosing keeps inflammation suppressed more evenly. For acute pain from a sprain or headache, though, Aleve has the advantage of being available without a prescription and kicking in without a doctor’s visit.
Stomach and Heart Safety
A pooled analysis of over 24,000 patients found that meloxicam at 7.5 mg daily carried a 0.03% risk of serious upper gastrointestinal events, significantly lower than the risk seen with naproxen, diclofenac, or piroxicam. The risk of blood clot-related cardiovascular events was similar between meloxicam and naproxen. Most of those patients were followed for up to 60 days, so the comparison is strongest for short-to-medium-term use.
The tradeoff with COX-2 selectivity is worth understanding. Drugs that lean heavily toward COX-2 inhibition (like the now-withdrawn rofecoxib) have been linked to increased cardiovascular risk at high doses. Meloxicam’s selectivity is moderate, not extreme, so its cardiovascular profile has held up better. Naproxen, meanwhile, is sometimes considered the NSAID with the most neutral cardiovascular profile because its strong COX-1 inhibition gives it mild blood-thinning properties. The flip side is that naproxen is harder on the stomach for the same reason.
Which One Makes More Sense for You
If you’re dealing with a one-time headache, menstrual cramps, or a minor injury, Aleve is the practical choice. It’s available without a prescription, effective within an hour, and works well for short-term use. You don’t need to see a doctor to get it.
Meloxicam is typically prescribed for ongoing inflammatory conditions like osteoarthritis or rheumatoid arthritis, where you need reliable daily pain control with less stomach risk over weeks or months. Its once-daily dosing and gentler gastrointestinal profile make it better suited for long-term management. But it requires a prescription, and at comparable doses, it doesn’t meaningfully outperform naproxen on raw pain relief.
The honest answer to “is meloxicam stronger” is that it’s not. It’s more targeted. At equivalent prescription doses, the two produce similar pain relief. The differences that actually matter are meloxicam’s easier dosing schedule, its lower rate of stomach complications, and the fact that it requires a prescription while Aleve does not.